Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. (Q34616803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Veli-Matti Kähäri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

157-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11979428%20AND%20SRC:MED&resulttype=core&format=json

Matrix metalloproteinases

10 December 2019

cites work

1 reference

Matrix metalloproteinase degradation of extracellular matrix: biological consequences

21 January 2018

1 reference

Human collagenase-3 is expressed in malignant squamous epithelium of the skin

21 January 2018

1 reference

Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas.

21 January 2018

1 reference

Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas

21 January 2018

1 reference

Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor

21 January 2018

1 reference

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

21 January 2018

1 reference

Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer

21 January 2018

1 reference

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense

21 January 2018

1 reference

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

21 January 2018

1 reference

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

21 January 2018

1 reference

Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members

21 January 2018

1 reference

Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors

21 January 2018

1 reference

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

21 January 2018

1 reference

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

Matrix metalloproteinases and their inhibitors in tumour growth and invasion

21 January 2018

1 reference

Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin

21 January 2018

1 reference

In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy

21 January 2018

1 reference

Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.

21 January 2018

1 reference

Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis

21 January 2018

1 reference

Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness

21 January 2018

1 reference

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma

21 January 2018

1 reference

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

21 January 2018

1 reference

Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?

21 January 2018

1 reference

Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

21 January 2018

1 reference

Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.

21 January 2018

1 reference

Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma

21 January 2018

1 reference

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

21 January 2018

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

21 January 2018

1 reference

Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis

21 January 2018

1 reference

Promising new developments in cancer chemotherapy

21 January 2018

1 reference

Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).

21 January 2018

1 reference

Role of matrix metalloproteinases in abdominal aortic aneurysms

21 January 2018

1 reference

Ongoing trials with matrix metalloproteinase inhibitors

21 January 2018

1 reference

High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma

21 January 2018

1 reference

The clinical significance of MMP-1 expression in oesophageal carcinoma

21 January 2018

1 reference

Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival

21 January 2018

1 reference

Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage

21 January 2018

1 reference

Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer

21 January 2018

1 reference

Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

21 January 2018

1 reference

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

21 January 2018

1 reference

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

Development of matrix metalloproteinase inhibitors in cancer therapy.

21 January 2018

1 reference

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

21 January 2018

1 reference

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

21 January 2018

1 reference

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

21 January 2018

1 reference

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies

21 January 2018

1 reference

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer

21 January 2018

1 reference

Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.

21 January 2018

1 reference

MMP inhibition and downregulation by bisphosphonates.

21 January 2018

1 reference

Matrix metalloproteinase inhibitors: applications in oncology.

21 January 2018

1 reference

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

21 January 2018

1 reference

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

21 January 2018

1 reference

Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.

21 January 2018

1 reference